Citation Impact
Citing Papers
Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2
2011 Standout
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
2010 Standout
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid
2007 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Obesity alters gut microbial ecology
2005 Standout
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
2008 Standout
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
2013 Standout
Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy
2007
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
2006 Standout
Pancreatic cancer
2004 Standout
Distal Small Bowel Hormones (Correlation with Fasting Antroduodenal Motility and Gastric Emptying)
1998
The tor pathway: a target for cancer therapy
2004 Standout
Medroxyprogesterone, interferon alfa‐2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis
2007
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome
2015 StandoutNature
Mediators for fat-induced ileal brake are different between stomach and proximal small intestine in conscious dogs
2001
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Gut biogeography of the bacterial microbiota
2015 Standout
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans
1993
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
2000 StandoutNobel
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Classification and functions of enteroendocrine cells of the lower gastrointestinal tract
2011
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
Pancreatic Adenocarcinoma
2014 Standout
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
Signalling pathways of the TNF superfamily: a double-edged sword
2003 Standout
Is small intestinal permeability really increased in relatives of patients with Crohn's disease?
1993
Intestinal mucosal barrier function in health and disease
2009 Standout
Intestinal Permeability Test As A Predictor of Clinical Course in Crohn's Disease
1999
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
2016 Standout
Tumor delivery of macromolecular drugs based on the EPR effect
2010 Standout
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
The Physiology of Glucagon-like Peptide 1
2007 Standout
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease
2002
Pancreatic Cancer
2010 Standout
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
The ileal brake: A fifteen-year progress report
1999
CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability
1995
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
The dawning era of polymer therapeutics
2003 Standout
Tropical sprue is associated with contamination of small bowel with aerobic bacteria and reversible prolongation of orocecal transit time
2003
Pancreatic cancer
2011 Standout
Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat
1998
Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
2007
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Dialogue between E. coli free radical pathways and the mitochondria of C. elegans
2015 StandoutNobel
The short chain fatty acids, butyrate and propionate, have differential effects on the motility of the guinea pig colon
2014
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
2007
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Introduction to the human gut microbiota
2017 Standout
Inflammatory Bowel Disease
2010 Standout
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
2009 Standout
Innovations and Challenges in Renal Cell Carcinoma: Summary Statement from the Second Cambridge Conference
2007 StandoutNobel
TROPHIC AND CYTOPROTECTIVE NUTRITION FOR INTESTINAL ADAPTATION , MUCOSAL REPAIR, AND BARRIER FUNCTION
2003
Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma
2004
Pegylated Interferon Alfa-2b Treatment for Patients With Solid Tumors: A Phase I/II Study
2002
Inflammatory bowel disease is associated with changes of enterocytic junctions
2001
Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities
2001
Works of E Ruggeri being referenced
Morphologic and Cytoproliferative Patterns of Duodenal Mucosa in Two Patients After Long‐term Total Parenteral Nutrition: Changes With Oral Refeeding and Relation to Intestinal Resection
1994
Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease
1990
Fat-induced heal brake in humans: A dose-dependent phenomenon correlated to the plasma levels of peptide YY
1993
Gemcitabine-based polychemotherapy for advanced pancreatic cancer (APC): Is it ready for prime time? A pooled analysis of 3,682 patients (pts) enrolled in 12 phase III trials
2006
Current status of targeted agents in advanced pancreatic cancer (APC): A pooled analysis of 2,361 patients (pts) enrolled in six phase III trials
2006
Home Artificial Nutrition in Advanced Cancer
1997
Interleukin-2, Interferon-α and Interleukin-2 plus Interferon-α in Renal Cell Carcinoma. A Randomized Phase Ii Trial
1998